This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dias Da Silva, M. R. Articles by Maciel, R. M. B. Search for Related Content PubMed PubMed Citation Articles by Dias Da Silva, M. R. Articles by Maciel, R. M. B.

A Mutation in the KCNE3 Potassium Channel Gene Is Associated with Susceptibility to Thyrotoxic Hypokalemic Periodic Paralysis

Laboratory of Molecular Endocrinology, Division of Endocrinology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil

Abstract

Hypokalemic Periodic Paralyses comprise diverse diseases characterized by acute and reversible attacks of severe muscle weakness, associated with low serum potassium. The most common causes are Familial Hypokalemic Periodic Paralysis (FHypoKPP), an autosomal dominant disease, and Thyrotoxic Hypokalemic Periodic Paralysis (THypoKPP), secondary to thyrotoxicosis. Symptoms of paralysis are similar in both diseases, distinguished by thyrotoxicosis present in THypoKPP. FHypoKPP is caused by mutations in ionic channel genes calcium (CACN1AS), sodium (SCN4A) and potassium (KCNE3). Since both diseases are similar, we tested the hypothesis that THypoKPP could carry the same mutations described in FHypoKPP, being the paralysis a genetically conditioned complication of thyrotoxicosis. In 15 patients with THypoKPP, using target-exon PCR, CSGE screening, and direct sequencing, we excluded known mutations in CACN1AS and SCN4A genes. On the other hand, we were able to identify the R83H mutation in the KCNE3 gene in one sporadic case of THypoKPP, a man who had been asymptomatic until developing thyrotoxicosis caused by Graves’ disease; we confirmed the disease-causing mutation in 2 of 3 descendants. R83H was recently found in two FHypoKPP unrelated families, in which the mutant decreased outward potassium flux, resulting in a more positive resting membrane potential. We, therefore, identified the first genetic defect in THypoKPP, a mutation in the KCNE3 gene.

This article has been cited by other articles:

				R. Sinharay Thyrotoxic periodic paralysis amongst the ethnic Asians living in the west--an important entity to consider in the hospital setting QJM, May 1, 2009; 102(5): 361 - 362. [Full Text] [PDF]

				F. Vendrame, A. Verrienti, C. Parlapiano, S. Filetti, F. Dotta, and S. Morano Thyrotoxic periodic paralysis in an Italian man: clinical manifestation and genetic analysis Ann Clin Biochem, March 1, 2008; 45(2): 218 - 220. [Abstract] [Full Text] [PDF]

				A. W. C. Kung Thyrotoxic Periodic Paralysis: A Diagnostic Challenge J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2490 - 2495. [Abstract] [Full Text] [PDF]

				Y. Li, S. Y. Um, and T. V. Mcdonald Voltage-Gated Potassium Channels: Regulation by Accessory Subunits Neuroscientist, June 1, 2006; 12(3): 199 - 210. [Abstract] [PDF]

				S. L. Venance, S. C. Cannon, D. Fialho, B. Fontaine, M. G. Hanna, L. J. Ptacek, M. Tristani-Firouzi, R. Tawil, R. C. Griggs, and the CINCH investigators The primary periodic paralyses: diagnosis, pathogenesis and treatment Brain, January 1, 2006; 129(1): 8 - 17. [Abstract] [Full Text] [PDF]

				S. Bendahhou, C. Marionneau, K. Haurogne, M.-M. Larroque, R. Derand, V. Szuts, D. Escande, S. Demolombe, and J. Barhanin In vitro molecular interactions and distribution of KCNE family with KCNQ1 in the human heart Cardiovasc Res, August 15, 2005; 67(3): 529 - 538. [Abstract] [Full Text] [PDF]

				T. M. Miller, M. R. Dias da Silva, H. A. Miller, H. Kwiecinski, J. R. Mendell, R. Tawil, P. McManis, R. C. Griggs, C. Angelini, S. Servidei, et al. Correlating phenotype and genotype in the periodic paralyses Neurology, November 9, 2004; 63(9): 1647 - 1655. [Abstract] [Full Text] [PDF]

				K. Jurkat-Rott and F. Lehmann-Horn Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation Neurology, March 23, 2004; 62(6): 1012 - 1015. [Abstract] [Full Text] [PDF]

				A. W. C. Kung, K. S. Lau, G. C. Y. Fong, and V. Chan Association of Novel Single Nucleotide Polymorphisms in the Calcium Channel {alpha}1 Subunit Gene (Cav1.1) and Thyrotoxic Periodic Paralysis J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1340 - 1345. [Abstract] [Full Text] [PDF]

				R Sinharay Hypokalaemic thyrotoxic periodic paralysis in an Asian man in the United Kingdom Emerg. Med. J., January 1, 2004; 21(1): 120 - 121. [Abstract] [Full Text] [PDF]

				D. Sternberg, N. Tabti, E. Fournier, B. Hainque, and B. Fontaine Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis Neurology, September 23, 2003; 61(6): 857 - 859. [Abstract] [Full Text] [PDF]

				R. Sinharay Hypokalaemic thyrotoxic periodic paralysis in the UK QJM, August 1, 2003; 96(8): 611 - 613. [Full Text] [PDF]

				L. J. Ptacek Channel Surfing J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4879 - 4880. [Full Text] [PDF]